|
業務類別
|
Biotechnology |
|
業務概覽
|
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006. |
| 公司地址
| 230 Harriet Tubman Way, Millbrae, CA, USA, 94030 |
| 電話號碼
| +1 341 777-0566 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.eikontx.com |
| 員工數量
| 384 |
| Mr. Michael A Klobuchar |
Chief Operating Officer |
-- |
28/01/2026 |
| Mr. Benjamin Thorner |
Chief Business Officer and General Counsel |
-- |
28/01/2026 |
| Dr. Alfred Bowie |
Chief Financial Officer and Principal Accounting Officer |
-- |
28/01/2026 |
| Dr. Roger M. Perlmutter,M.D.,PhD |
Chief Executive Officer and Chairman of the Board |
-- |
28/01/2026 |
| Dr. Roy D. Baynes, M.D.,PhD |
Chief Medical Officer |
-- |
28/01/2026 |
|
|
| Mr. Robert Huffines |
Independent Director |
28/01/2026 |
| Dr. Leon Chen, PhD |
Director |
28/01/2026 |
| Mr. David W. Meline |
Independent Director |
28/01/2026 |
| Mr. Kenneth C. Frazier |
Independent Director |
28/01/2026 |
| Dr. Roger M. Perlmutter,M.D.,PhD |
Chief Executive Officer and Chairman of the Board |
28/01/2026 |
| Mr. Joshua Wolfe |
Director |
28/01/2026 |
|
|
|
|
